141 related articles for article (PubMed ID: 7753016)
1. [Correlation of DNA ploidy, c-erB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
Takamura H; Yonemura Y; Fonseca L; Ninomiya I; Tsugawa K; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1995 Apr; 96(4):213-22. PubMed ID: 7753016
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
Takamura H; Yonemura Y; Hirono Y; Ninomiya I; Sahara H; Tsugawa K; Matsumoto H; Sugiyama K; Fujimura T; Nishimura G
Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
Tamaki M; Maeda S; Deguchi T; Kawada Y
Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
[TBL] [Abstract][Full Text] [Related]
5. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
7. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
Saiki I; Une Y; Uchino J
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
[TBL] [Abstract][Full Text] [Related]
10. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma.
Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH
J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
13. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content].
Nakano S; Kawamura J
Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033
[TBL] [Abstract][Full Text] [Related]
14. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa.
Wang Z; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 1997; 17(5A):3701-5. PubMed ID: 9413227
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
[TBL] [Abstract][Full Text] [Related]
16. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 expression in primary gastric carcinomas and their metastases.
David L; Seruca R; Nesland JM; Soares P; Sansonetty F; Holm R; Børresen AL; Sobrinho-Simões M
Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Morita K; Hayashi Y; Nagao S; Watanabe Y
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ.
Schimmelpenning H; Eriksson ET; Pallis L; Skoog L; Cedermark B; Auer GU
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S48-52. PubMed ID: 1374218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]